215 related articles for article (PubMed ID: 21193968)
21. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
Zinzani PL; Magagnoli M; Pagliani G; Bendandi M; Gherlinzoni F; Merla E; Salvucci M; Tura S
Haematologica; 1997; 82(3):305-8. PubMed ID: 9234576
[TBL] [Abstract][Full Text] [Related]
22. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
24. Localised extranodal non-Hodgkin's lymphoma of the gastrointestinal tract: Sheffield Lymphoma Group experience (1989-1998).
Koh PK; Horsman JM; Radstone CR; Hancock H; Goepel JR; Hancock BW
Int J Oncol; 2001 Apr; 18(4):743-8. PubMed ID: 11251169
[TBL] [Abstract][Full Text] [Related]
25. A retrospective comparison of early stage primary extranodal with nodal non-Hodgkin lymphoma patients: A single center experience.
Yazilitas D; Ozdemir N; Hocazade C; Bozkaya Y; Yazici O; Sendur MA; Zengin N
J BUON; 2015; 20(6):1526-33. PubMed ID: 26854450
[TBL] [Abstract][Full Text] [Related]
26. Should children with non-Hodgkin lymphoma be treated with different protocols according to histopathologic subtype?
Lee SH; Yoo KH; Sung KW; Ko YH; Lee JW; Koo HH
Pediatr Blood Cancer; 2013 Nov; 60(11):1842-7. PubMed ID: 23857875
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology and Determinants of Survival for Primary Intestinal Non-Hodgkin Lymphoma: A Population-Based Study.
Singh V; Gor D; Gupta V; Jacob A; Du D; Eltoukhy H; Meghal T
World J Oncol; 2022 Aug; 13(4):159-171. PubMed ID: 36128593
[TBL] [Abstract][Full Text] [Related]
28. [Prognostic significance of the histological classification and staging for patients with a malignant non-Hodgkin lymphoma].
Raemaekers JM; Snoeijen JJ; Bogman MJ; Rutten E; Strijk SP; Manni JJ
Ned Tijdschr Geneeskd; 1993 Apr; 137(16):815-20. PubMed ID: 8487885
[TBL] [Abstract][Full Text] [Related]
29. [Clinical study of 22 cases of primary gastrointestinal lymphoma].
Song LP; Hou HL; Zhao H; Zheng W; Zhang L; Gao J
Ai Zheng; 2004 Jun; 23(6):685-8. PubMed ID: 15191671
[TBL] [Abstract][Full Text] [Related]
30. Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy.
Pinnix CC; Osborne EM; Chihara D; Lai P; Zhou S; Ramirez MM; Oki Y; Hagemeister FB; Rodriguez AM; Samaniego F; Fowler N; Romaguera JE; Turturro F; Fayad L; Westin JR; Nastoupil L; Neelapu SS; Cheah CY; Dabaja BS; Milgrom SA; Smith GL; Horace P; Milbourne A; Wogan CF; Ballas L; Fanale MA
JAMA Oncol; 2016 Aug; 2(8):1065-9. PubMed ID: 27227654
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO.
d'Amore F; Johansen P; Houmand A; Weisenburger DD; Mortensen LS
Blood; 1996 Feb; 87(3):1045-55. PubMed ID: 8562929
[TBL] [Abstract][Full Text] [Related]
32. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
33. Malignant intestinal non-Hodgkin's lymphoma from the surgical point of view.
Samel S; Wagner J; Hofheinz R; Sturm J; Post S
Onkologie; 2002 Jun; 25(3):268-71. PubMed ID: 12119462
[TBL] [Abstract][Full Text] [Related]
34. Primary gastrointestinal non-Hodgkin's lymphoma: clinicopathological and prognostic analysis.
Wang T; Gui W; Shen Q
Med Oncol; 2010 Sep; 27(3):661-6. PubMed ID: 19565363
[TBL] [Abstract][Full Text] [Related]
35. The role of surgical management in primary small bowel lymphoma: A single-center experience.
Hong YW; Kuo IM; Liu YY; Yeh TS
Eur J Surg Oncol; 2017 Oct; 43(10):1886-1893. PubMed ID: 28751057
[TBL] [Abstract][Full Text] [Related]
36. [Clinical characteristics of 104 patients with primary gastrointestinal non-Hodgkin lymphoma].
Huang Y; Zhou D; Duan M; Li J; Han B; Zhuang J; Zhang W
Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):791-5. PubMed ID: 25246245
[TBL] [Abstract][Full Text] [Related]
37. Non-Hodgkin's lymphoma involving the ileocecal region: a single-institution analysis of 46 cases in a Chinese population.
Zhai L; Zhao Y; Lin L; Tian Y; Chen X; Huang H; Lin T
J Clin Gastroenterol; 2012 Jul; 46(6):509-14. PubMed ID: 22105183
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group.
d'Amore F; Christensen BE; Brincker H; Pedersen NT; Thorling K; Hastrup J; Pedersen M; Jensen MK; Johansen P; Andersen E
Eur J Cancer; 1991; 27(10):1201-8. PubMed ID: 1835586
[TBL] [Abstract][Full Text] [Related]
39. Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: the Milan Cancer Institute experience.
Tondini C; Giardini R; Bozzetti F; Valagussa P; Santoro A; Bertulli R; Balzarotti M; Rocca A; Lombardi F; Ferreri AJ
Ann Oncol; 1993 Dec; 4(10):831-7. PubMed ID: 8117602
[TBL] [Abstract][Full Text] [Related]
40. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
